SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Longer term short term day trades.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Steve Felix10/18/2025 10:45:16 AM
   of 1904
 
ATAI makes two in a short time. Closed down .38 on Thursday at $5.48. Announced an over 23 million share
offering after hours at $5.98. Friday, traded as low as $5.38, before reversing to close up over 17% at $6.45
on 31 million shares.

05:01 PM EDT, 10/16/2025 (MT Newswires) -- Atai Life Sciences (ATAI) and Beckley Psytech said late
Thursday the US Food and Drug Administration has granted Breakthrough Therapy designation to BPL-003
nasal spray formulation for adult patients with treatment-resistant depression.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News